Loading
Sedana Medical AB (publ) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Hilde Furberg, was filed 12 Nov 2025.
Sedana Medical AB (publ): what insiders have been doing
Sedana Medical AB (publ) is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. The last twelve months, up to 24 October 2026, brought 2 filings signed by 2 insiders.
Purchases and sales both appear in the filings: 1 purchase (1 insider, €1,787) and 1 sale (1 insider, €17k). Taken together, the sales exceed the purchases by €15k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a sale of €17k from Jens Viebke, disclosed on 10 March 2026, or 0.016% of market capitalisation. The buyers include 1 board member.
For context, the typical company on the same exchange (median of 1,028 companies) published 9 filings over the same period, against 2 filings here. The full history, which starts in 2017, counts 9 purchases against 33 sales.
The last purchase on record was published on 12 November 2025, which is 346 days ago.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
84
Thresholds
n/a
Buy Volume
€9M
9 ops. · all time
Sell Volume
€25M
33 ops. · all time
Who traded when
BuySaleChristoffer Björn Rosenblad1 buy
Hilde Furberg1 buy
Jens Viebke1 sale
Stefan Krisch1 buy
Analyst consensus: bullish or bearish?
Analysts rate Sedana Medical AB (publ) Buy (bullish), based on 1 analysts. Average price target: SEK 18.00.
Fundamental score
Ranked 21,566 of 26,286 companies
29.0
score / 100
Value19
Quality39
FCF yld-8.0%
Earn yld-6.3%
EV/EBITDA·
ROE-4.0%
Gross mgn71%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 9.44
Analyst consensus
1 analystsBuy
SEK 18.00Target SEK 18.00(+91%)SEK 18.00
Income statement
RevenueSEK 200.2M
Gross profitSEK 142.7M71% margin
EBITDA-SEK 33.8M-17% margin
Net income-SEK 59.2M-18.3% margin
Valuation
PER (forward)472.0x
P/Book1.1x
Beta0.87
Balance sheet & cash
Market capSEK 937.7M
Total debtSEK 4.7M
Free Cash Flow-SEK 75.2M
Debt / Equity1%
Profitability & ownership
ROE-4.0%
ROA-2.2%
% insiders18.6%
% institutions46.6%
Last declaration on 10 March 2026
Declarations84 total
20,000 shares@ SEK 8.95410.016% mcap100.0% of flowAktieISIN SE0015988373FI:A003W901-1
2,000 shares@ SEK 9.8522.5% of flowAktieISIN SE0015988373FI:csv-09004d119f204337864f
Canonical exit: 8 Feb 2026 (T+90)
10,000 shares@ SEK 10.100.0089% mcap100.0% of flowAktieISIN SE0015988373FI:A003M743-1
Canonical exit: 16 Jun 2025 (T+90)
6,000 shares@ SEK 16.7625.9% of flowAktieISIN SE0015988373FI:csv-76d11f900befc61605e0
Canonical exit: 11 Mar 2025 (T+90)
10,000 shares@ SEK 14.7238.3% of flowAktieISIN SE0015988373FI:csv-d3cb71981c8ab12b039d
Canonical exit: 23 Jan 2025 (T+90)
6,000 shares@ SEK 23.0035.8% of flowAktieISIN SE0015988373FI:csv-ec590110072476eeb431
Canonical exit: 8 Dec 2024 (T+90)
3,000 shares@ SEK 21.4295100.0% of flowAktieISIN SE0015988373FI:csv-f4c531f995ca023ce3d9
Canonical exit: 19 Oct 2022 (T+90)
20,000 shares@ SEK 340.058AktieISIN SE0009947534FI:csv-4738a49ca92a2b6f7fac
4,000 shares0AktieISIN SE0009947534FI:csv-994e1302076988a31f77
5,000 shares@ SEK 285.00AktieISIN SE0009947534FI:csv-327dd8f975bb59278b3f
259 shares@ SEK 295.00AktieISIN SE0009947534FI:csv-73f77b4af0994daa802d
2 shares@ SEK 292.00AktieISIN SE0009947534FI:csv-b630867d5dda630dff7f
15,000 shares@ SEK 290.00AktieISIN SE0009947534FI:csv-3ba43448b8519def3780
3,333 shares@ SEK 270.00AktieISIN SE0009947534FI:csv-30d79cb1b9dbbdceb4b9
5,000 shares@ SEK 265.00AktieISIN SE0009947534FI:csv-46255044e2befe661e52
4,124 shares@ SEK 255.00AktieISIN SE0009947534FI:csv-0bf46a8d59bbff5facdd
1,891 shares@ SEK 260.00AktieISIN SE0009947534FI:csv-eb7961b44c8932773174
1,072 shares@ SEK 231.00AktieISIN SE0009947534FI:csv-b8bbe4de6c92e5d90b94
Canonical exit: 18 Feb 2021 (T+90)
3,000 shares@ SEK 250.00AktieISIN SE0009947534FI:csv-b25c76757b6af59a10c1
75,000 shares@ SEK 260.00AktieISIN SE0009947534FI:csv-4a2e977367faab2ff959
1,858 shares@ SEK 250.00AktieISIN SE0009947534FI:csv-a2aeb4492a5d73cde997
18,142 shares@ SEK 225.00AktieISIN SE0009947534FI:csv-51efd642fcbf7b3aa245
65,167 shares@ SEK 25.35100.0% of flowAktieISIN SE0009947534FI:csv-8aac2ff5fba4469f5063
65,167 shares0TeckningsoptionFI:csv-b19e54609d3fcd008571
16,658 shares@ SEK 225.00AktieISIN SE0009947534FI:csv-9163363e4b094b648367
25 of 84 declarations
About Sedana Medical AB (publ)
Sedana Medical AB (publ) is a Swedish company focused on developing medical solutions for anesthesia and pain management. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
